Because of this obvious contradiction, we aimed to confirm in a model for polygenic obesity and diabetes, the New Zealand obese (NZO) mouse, the beneficial effects of FGF21 that have been observed in other models. This evidence concerns the gene FGF21 and diabetes mellitus.